Suzanne Topalian
Director, Johns Hopkins Melanoma/Skin Cancer Program · Johns Hopkins University School of Medicine
Credentials: · ·
History
- Present
Johns Hopkins Melanoma/Skin Cancer Program · Johns Hopkins University School of Medicine
Surgery
Research
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
New England Journal of Medicine · 2012 · First of 30 authors · Corresponding · 10,404 citations
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
New England Journal of Medicine · 2012 · 6,533 citations
Immune checkpoint blockade: a common denominator approach to cancer therapy
Review · Cancer Cell · 2015 · First of 3 authors · Corresponding · 3,416 citations
68 papers · 1 as a fellow
43 papers · 1 as a fellow
- DS
35 papers
32 papers
- EL
20 papers
18 papers · 1 as a fellow
17 papers
16 papers
Grants
- 2010–2027
PD-1/PD-L1 Modulation in Cancer Therapy
National Cancer Institute · R01
PI · $7.9M · Johns Hopkins University
- 2008–2013
Recognition of Self and Mutated Self by Autoimmune and Tumor-Specific TCRs
National Institute of Allergy and Infectious Diseases · R01
PI · $2M · Univ of Maryland, College Park